Rua launches NZ$2.8m capital raise in bid to continue revenue growth by Steve Jones September 25, 2026September 25, 2026 New Zealand supplier Rua Bioscience is aiming to raise up to NZ$2.8 million (A$2.25m) as it […]
It’s professionals, not products who will write the next chapter of medicinal cannabis by Dr Davin Gunn June 22, 2026June 22, 2026
Ora Pharm buys key Helius Therapeutics assets in major NZ deal by Adam Sheldon May 13, 2026May 13, 2026
ECS bucks market downturn with third consecutive positive quarter by Adam Sheldon April 28, 2026April 28, 2026
We just couldn’t grow fast enough, Helius CEO reveals amid warning for firms to be ‘realistic’ by Adam Sheldon March 26, 2026March 26, 2026
Puro cannabis beats wine to win Marlborough’s top business award by Adam Sheldon November 25, 2025February 21, 2026
New data: Australia and NZ markets maturing amid regulatory changes by Adam Sheldon November 5, 2025February 21, 2026
‘Fairness and justice’: Rua pushes for cannabis decriminalisation in NZ by Adam Sheldon September 23, 2025February 21, 2026
